Anti-PUR9/ ATIC/ AICAR monoclonal antibody
Anti-PUR9/ ATIC/ AICAR antibody for FACS & in-vivo assay
Go to ATIC/ATIC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T04741-Ab-1/ GM-Tg-hg-T04741-Ab-2 | Anti-Human ATIC monoclonal antibody | Human |
GM-Tg-rg-T04741-Ab-1/ GM-Tg-rg-T04741-Ab-2 | Anti-Rat ATIC monoclonal antibody | Rat |
GM-Tg-mg-T04741-Ab-1/ GM-Tg-mg-T04741-Ab-2 | Anti-Mouse ATIC monoclonal antibody | Mouse |
GM-Tg-cynog-T04741-Ab-1/ GM-Tg-cynog-T04741-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ATIC monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T04741-Ab-1/ GM-Tg-felg-T04741-Ab-2 | Anti-Feline ATIC monoclonal antibody | Feline |
GM-Tg-cang-T04741-Ab-1/ GM-Tg-cang-T04741-Ab-2 | Anti-Canine ATIC monoclonal antibody | Canine |
GM-Tg-bovg-T04741-Ab-1/ GM-Tg-bovg-T04741-Ab-2 | Anti-Bovine ATIC monoclonal antibody | Bovine |
GM-Tg-equg-T04741-Ab-1/ GM-Tg-equg-T04741-Ab-2 | Anti-Equine ATIC monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T04741-Ab-1/ GM-Tg-hg-T04741-Ab-2; GM-Tg-rg-T04741-Ab-1/ GM-Tg-rg-T04741-Ab-2; GM-Tg-mg-T04741-Ab-1/ GM-Tg-mg-T04741-Ab-2; GM-Tg-cynog-T04741-Ab-1/ GM-Tg-cynog-T04741-Ab-2; GM-Tg-felg-T04741-Ab-1/ GM-Tg-felg-T04741-Ab-2; GM-Tg-cang-T04741-Ab-1/ GM-Tg-cang-T04741-Ab-2; GM-Tg-bovg-T04741-Ab-1/ GM-Tg-bovg-T04741-Ab-2; GM-Tg-equg-T04741-Ab-1/ GM-Tg-equg-T04741-Ab-2 |
Products Name | Anti-ATIC monoclonal antibody |
Format | mab |
Target Name | ATIC |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-ATIC benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species PUR9/ ATIC/ AICAR VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLP002037 | human ATIC Lentivirus plasmid |
ORF Viral Vector | vGMLP002037 | human ATIC Lentivirus particle |
ORF Viral Vector | pGMLPm003046 | mouse Atic Lentivirus plasmid |
ORF Viral Vector | vGMLPm003046 | mouse Atic Lentivirus particle |
Target information
Target ID | GM-T04741 |
Target Name | ATIC |
Gene ID | 471,108147,81643,694819,488513,101081485,506343,100054298 |
Gene Symbol and Synonyms | 2610509C24Rik,AICAR,AICARFT,ATIC,HEL-S-70p,IMPCHASE,PURH |
Uniprot Accession | P31939,O35567,Q0VCK0 |
Uniprot Entry Name | PUR9_HUMAN,PUR9_RAT,PUR9_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | Cancer |
Gene Ensembl | ENSG00000138363 |
Target Classification | Tumor-associated antigen (TAA) |
The target: ATIC, gene name: ATIC, also named as AICAR, AICARFT, HEL-S-70p, IMPCHASE, PURH. This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.